Schrödinger

Schrödinger is transforming molecular discovery with its computational platform, enabling the design of novel, optimized molecules for drug development and materials research. Built on over 30 years of R&D, the platform is used by biotechnology, pharmaceutical, industrial, and academic institutions worldwide. Schrödinger also advances a portfolio of collaborative and proprietary programs. Founded in 1990, the company has about 800 employees across 15 global locations.

www.schrodinger.com

Schrodinger - AI Convergence Small Molecules Discovery - Partner 2026
Schrodinger - AI Convergence Small Molecules Discovery - Partner 2026